ArticleAnnals of medicine and surgery (2012)2026

Efficacy and safety of risankizumab in moderate to severe psoriasis: an updated systematic review and meta-analysis.

Hafsa Shuja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.